Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies

Background: The metabolic syndrome (MS) is a clustering of different cardiovascular (CV) risk factors, which further enhances the risk of death and CV complications in post-acute myocardial infarction (AMI) patients. In the present meta-analysis of individual data of the four randomized, prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Borghi, Claudio, Omboni, Stefano, Reggiardo, Giorgio, Bacchelli, Stefano, Esposti, Daniela Degli, Ambrosioni, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564045/
http://dx.doi.org/10.1089/met.2016.0152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564045/
http://dx.doi.org/10.1089/met.2016.0152

Ejemplares similares